Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HLA-A2' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 535 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Maeurer, MJ; Necker, A; Salter, RD; Castelli, C; Hohn, H; Karbach, J; Freitag, K; Neukirch, C; Knuth, A; Jager, E
      Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/MART-1 peptide analogue

      INTERNATIONAL JOURNAL OF CANCER
    2. Riley, JP; Rosenberg, SA; Parkhurst, MR
      Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase

      JOURNAL OF IMMUNOTHERAPY
    3. Di Modugno, F; Buglioni, S; Mottolese, M; Del Bello, D; Cascioli, S; Chersi, A; Santoni, A; Nistico, P
      Polyclonal antibodies against gp185(HER2) peptides: Their putative role inthe identification of a particular HER2 status in patients with breast cancer

      JOURNAL OF IMMUNOTHERAPY
    4. Bownds, S; Tong-On, P; Rosenberg, SA; Parkhurst, M
      Induction of tumor-reactive cytotoxic T-lymphocytes using a peptide from NY-ESO-1 modified at the carboxy-terminus to enhance HLA-A2.1 binding affinity and stability in solution

      JOURNAL OF IMMUNOTHERAPY
    5. Lau, R; Wang, F; Jeffery, G; Marty, V; Kuniyoshi, J; Bade, E; Ryback, ME; Weber, J
      Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma

      JOURNAL OF IMMUNOTHERAPY
    6. Kao, H; Amoscato, AA; Ciborowski, P; Finn, OJ
      A new strategy for tumor antigen discovery based on in vitro priming of naive T cells with dendritic cells

      CLINICAL CANCER RESEARCH
    7. Nishiyama, T; Tachibana, M; Horiguchi, Y; Nakamura, K; Ikeda, Y; Takesako, K; Murai, M
      Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide

      CLINICAL CANCER RESEARCH
    8. Quesnel, A; Zerbib, A; Connan, F; Guillet, JG; Briand, JP; Choppin, J
      Synthesis and antigenic properties of reduced peptide bond analogues of animmunodominant epitope of the melanoma MART-1 protein

      JOURNAL OF PEPTIDE SCIENCE
    9. Jungbluth, AA; King, R; Fisher, DE; Iversen, K; Coplan, K; Kolb, D; Williamson, B; Chen, YT; Stockert, E; Old, LJ; Busam, KJ
      Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcriptionfactor in angiomyolipomas

      APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    10. Zhou, HC; Xu, DZ; Wang, XP; Zhang, JX; Huang, Y; Yan, YP; Zhu, Y; Jin, BQ
      Identification of the epitopes on HCV core protein recognized by HLA-A2 restricted cytotoxic T lymphocytes

      WORLD JOURNAL OF GASTROENTEROLOGY
    11. Jager, D; Jager, E; Knuth, A
      Targets for immunotherapy in breast cancer

      BREAST
    12. Logean, A; Sette, A; Rognan, D
      Customized versus universal scoring functions: Application to class I MHC-peptide binding free energy predictions

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    13. Kageshita, T; Kawakami, Y; Ono, T
      Clinical significance of MART-1 and HLA-A2 expression and CD8+T cell infiltration in melanocytic lesions in HLA-A2 phenotype patients

      JOURNAL OF DERMATOLOGICAL SCIENCE
    14. Tamura, M; Nishizaka, S; Maeda, Y; Ito, M; Harashima, N; Harada, M; Shichijo, S; Itoh, K
      Identification of cyclophilin B-derived peptides capable of inducing histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes

      JAPANESE JOURNAL OF CANCER RESEARCH
    15. Mazzocchi, A; Melani, C; Rivoltini, L; Castelli, C; Del Vecchio, M; Lombardo, C; Colombo, MP; Parmiani, G
      Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cellsto be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    16. Peter, K; Men, Y; Pantaleo, G; Gander, B; Corradin, G
      Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants

      VACCINE
    17. Propato, A; Schiaffella, E; Vicenzi, E; Francavilla, V; Baloni, L; Paroli, M; Finocchi, L; Tanigaki, N; Ghezzi, S; Ferrara, R; Chesnut, R; Livingston, B; Sette, A; Paganelli, R; Aiuti, F; Poli, G; Barnaba, V
      Spreading of HIV-specific CD8(+) T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity

      HUMAN IMMUNOLOGY
    18. So, T; Takenoyama, M; Sugaya, A; Yasuda, M; Eifuku, R; Yoshimatsu, T; Osaki, T; Yasumoto, K
      Unfavorable prognosis of patients with non-small cell lung carcinoma associated with HLA-A2

      LUNG CANCER
    19. Lam, MKP; Belov, K; Harrison, GA; Cooper, DW
      An Mhc class I gene in the Australian brushtail possum (Trichosurus vulpecula)

      IMMUNOGENETICS
    20. Castellanos, MR; Hayes, RL; Maiman, MA
      Synthetic peptides induce a cytotoxic response against human papillomavirus type-18

      GYNECOLOGIC ONCOLOGY
    21. Duquesnoy, RJ
      HLAMmatchmaker: A molecularly based donor selection algorithm for highly alloimmunized patients

      TRANSPLANTATION PROCEEDINGS
    22. Jager, D; Jagar, E; Knuth, A
      Vaccination for malignant melanoma: Recent developments

      ONCOLOGY
    23. Ono, T; Kurashige, T; Harada, N; Noguchi, Y; Saika, T; Niikawa, N; Aoe, M; Nakamura, S; Higashi, T; Hiraki, A; Wada, H; Kumon, H; Old, LJ; Nakayama, E
      Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    24. Satoi, J; Murata, K; Lechmann, M; Manickan, E; Zhang, ZS; Wedemeyer, H; Rehermann, B; Liang, TJ
      Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins

      JOURNAL OF VIROLOGY
    25. Hillig, RC; Coulie, PG; Stroobant, V; Saenger, W; Ziegler, A; Hulsmeyer, M
      High-resolution structure of HLA-A*0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene

      JOURNAL OF MOLECULAR BIOLOGY
    26. Frost, PA; Butterfield, LH; Dissette, VB; Economou, JS; Bonavida, B
      Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures

      JOURNAL OF IMMUNOLOGY
    27. Kao, H; Marto, JA; Hoffman, TK; Shabanowitz, J; Finkelstein, SD; Whiteside, TL; Hunt, DF; Finn, OJ
      Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells

      JOURNAL OF EXPERIMENTAL MEDICINE
    28. Kessler, JH; Beekman, NJ; Bres-Vloemans, SA; Verdijk, P; van Veelen, PA; Kloosterman-Joosten, AM; Vissers, DCJ; ten Bosch, GJA; Kester, MGD; Sijts, A; Drijfhout, JW; Ossendorp, F; Offringa, R; Melief, CJM
      Efficient identification of novel HLA-A*0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis

      JOURNAL OF EXPERIMENTAL MEDICINE
    29. Jager, D; Jager, E; Knuth, A
      Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer

      JOURNAL OF CLINICAL PATHOLOGY
    30. Tanaka, Y; Amos, KD; Joo, HG; Eberlein, TJ; Goedegebuure, PS
      Modification of the HER2/neu-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytes

      INTERNATIONAL JOURNAL OF CANCER
    31. Imai, N; Harashima, N; Ito, M; Miyagi, Y; Harada, M; Yamada, A; Itoh, K
      Identification of Lck-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with distant metastases

      INTERNATIONAL JOURNAL OF CANCER
    32. Wurtzen, PA; Pedersen, LO; Poulsen, HS; Claesson, MH
      Specific killing of P53 mutated tumor cell lines by a cross-reactive humanHLA-A2-restricted P53-specific CTL line

      INTERNATIONAL JOURNAL OF CANCER
    33. Griffioen, M; Borghi, M; Schrier, PI; Osanto, S
      Detection and quantification of CD8(+) T cells specific for HLA-A*0201-binding melanoma and viral peptides by the IFN-gamma-elispot assay

      INTERNATIONAL JOURNAL OF CANCER
    34. Benlalam, H; Labarriere, N; Linard, B; Derre, L; Diez, E; Pandolfino, MC; Bonneville, M; Jotereau, F
      Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy

      EUROPEAN JOURNAL OF IMMUNOLOGY
    35. Jager, D; Stockert, E; Gure, AO; Scanlan, MJ; Karbach, J; Jager, E; Knuth, A; Old, LJ; Chen, YT
      Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library

      CANCER RESEARCH
    36. Harada, M; Li, YF; El-Gamil, M; Rosenberg, SA; Robbins, PF
      Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A*0201-restricted T cells

      CANCER RESEARCH
    37. Dutoit, V; Rubio-Godoy, V; Dietrich, PY; Quiqueres, AL; Schnuriger, V; Rimoldi, D; Lienard, D; Speiser, D; Guillaume, P; Batard, P; Cerottini, JC; Romero, P; Valmori, D
      Heterogeneous T-cell response to MAGE-A10(254-262): High avidity-specific cytolytic T lymphocytes show superior antitumor activity

      CANCER RESEARCH
    38. Pinilla, C; Rubio-Godoy, V; Dutoit, V; Guillaume, P; Simon, R; Zhao, YD; Houghten, RA; Cerottini, JC; Romero, P; Valmori, D
      Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes

      CANCER RESEARCH
    39. Kurashige, T; Noguchi, Y; Saika, T; Ono, T; Nagata, Y; Jungbluth, A; Ritter, G; Chen, YT; Stockert, E; Tsushima, T; Kumon, H; Old, LJ; Nakayama, E
      NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: Correlation with tumor grade

      CANCER RESEARCH
    40. Dyall, J; Latouche, JB; Schnell, S; Sadelain, M
      Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes

      BLOOD
    41. Mosse, CA; Hsu, W; Engelhard, VH
      Tyrosinase degradation via two pathways during reverse translocation to the cytosol

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    42. Lauemoller, SL; Holm, A; Hilden, J; Brunak, S; Nissen, MH; Stryhn, A; Pedersen, LO; Buus, S
      Quantitative predictions of peptide binding to MHC class I molecules usingspecificity matrices and anchor-stratified calibrations

      TISSUE ANTIGENS
    43. Jager, E; Jager, D; Knuth, A
      Perspectives of tumour immunology: antigen-specific immunotherapy of malignant diseases

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    44. Tjoa, BA; Murphy, GP
      Progress in active specific immunotherapy of prostate cancer

      SEMINARS IN SURGICAL ONCOLOGY
    45. Engelhard, VH; Bullock, TNV; Colella, TA; Mullins, DW
      Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use

      CANCER JOURNAL
    46. Rosenberg, SA
      The identification of cancer antigens: Impact on the development of cancervaccines

      CANCER JOURNAL
    47. Bettinotti, MP; Norris, RD; Hackett, JA; Thompson, CO; Simonis, TB; Stroncek, D; Marincola, FM
      Frequency of human leukocyte antigen-A 24 alleles in patients with melanoma determined by human leukocyte antigen-A sequence-based typing

      JOURNAL OF IMMUNOTHERAPY
    48. Philip, R; Alters, SE; Brunette, E; Ashton, J; Gadea, J; Yau, J; Lebkowski, J; Philip, M
      Dendritic cells loaded with MART-1 peptide or infected with adenoviral construct are functionally equivalent in the induction of tumor-specific cytotoxic T lymphocyte responses in patients with melanoma

      JOURNAL OF IMMUNOTHERAPY
    49. Jones, LA; Salgaller, ML
      Immunologic approaches to antigen discovery for cancer vaccines

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    50. Latouche, JB; Sadelain, M
      Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells

      NATURE BIOTECHNOLOGY
    51. Rosenberg, SA
      Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    52. Bodinier, M; Peyrat, MA; Tournay, C; Davodeau, F; Romagne, F; Bonneville, M; Lang, F
      Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding

      NATURE MEDICINE
    53. Oelke, M; Moehrle, U; Chen, JL; Behringer, D; Cerundolo, V; Lindemann, A; Mackensen, A
      Generation and purification of CD8(+) Melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy

      CLINICAL CANCER RESEARCH
    54. Baker, BM; Gagnon, SJ; Biddison, WE; Wiley, DC
      Conversion of a T cell antagonist into an agonist by repairing a defect inthe TCR/peptide/MHC interface: Implications for TCR signaling

      IMMUNITY
    55. Small, GW
      Investigations into geriatric psychiatry challenges - AAGP Senior Investigator Award 2000

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    56. Seki, N; Yamada, A; Suefuji, Y; Mine, T; Tanaka, S; Gomi, SY; Kawagoe, N; Koufuji, K; Itoh, K
      Establishment and epitope analysis of allo-specific cytotoxic T lymphocytes at a tumor site recognizing a spouse's HLA-A0206 molecule

      AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
    57. Robinson, C; Callow, M; Stevenson, S; Scott, B; Robinson, BWS; Lake, RA
      Serologic responses in patients with malignant mesothelioma - Evidence forboth public and private specificities

      AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
    58. Schueler-Furman, O; Altuvia, Y; Sette, A; Margalit, H
      Structure-based prediction of binding peptides to MHC class I molecules: Application to a broad range of MHC alleles

      PROTEIN SCIENCE
    59. Chen, Q; Jackson, H; Cebon, J; Gibbs, P; Davis, ID; Trapani, JA
      A direct comparison of cytolytic T-lymphocyte responses to Melan-A peptides in vitro: differential immunogenicity of Melan-A(27-35) and Melan-A(26-35)

      MELANOMA RESEARCH
    60. Meng, WS; von Grafenstein, H; Haworth, IS
      Water dynamics at the binding interface of four different HLA-A2-peptide complexes

      INTERNATIONAL IMMUNOLOGY
    61. Stevens, J; Wiesmuller, KH; Butcher, GW; Joly, E
      Analysis of peptide length preference of the rat MHC class Ia molecule RT1-A(u), by a modified random peptide library approach

      INTERNATIONAL IMMUNOLOGY
    62. Knuth, A; Jager, D; Jager, E
      Cancer immunotherapy in clinical oncology

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    63. Jungbluth, AA; Iversen, K; Coplan, K; Kolb, D; Stockert, E; Chen, YT; Old, LJ; Busam, K
      T311 - An anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues

      PATHOLOGY RESEARCH AND PRACTICE
    64. McArdle, SEB; Rees, RC; Mulcahy, KA; Saba, J; McIntyre, CA; Murray, AK
      Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    65. Harris, JM; Cumming, AM; Craddock, N; St Clair, D; Lendon, CL
      Human leucocyte antigen-A2 increases risk of Alzheimer's disease but does not affect age of onset in a Scottish population

      NEUROSCIENCE LETTERS
    66. Calogero, A; Hospers, GAP; Kruse, KM; Schrier, PI; Mulder, NH; Hooijberg, E; De Leij, LFMH
      Retargeting of a T cell line by anti Mage-3/HLA-A2 alpha beta TCR gene transfer

      ANTICANCER RESEARCH
    67. Marastoni, M; Bazzaro, M; Gavioli, R; Micheletti, F; Traniello, S; Tomatis, R
      Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    68. Ellis, JM; Henson, V; Slack, R; Ng, J; Hartzman, RJ; Hurley, CK
      Frequencies of HLA-A2 alleles in five US population groups - Predominance of A*02011 and identification of HLA-A*0231

      HUMAN IMMUNOLOGY
    69. Stegmann, S; Muller, A; Zavazava, N
      Synthetic HLA-A2 derived peptides are recognized and presented in renal graft recipients

      HUMAN IMMUNOLOGY
    70. Staege, MS; Schneider, J; Eulitz, M; Scholz, S; Bornkamm, GW; Wolfel, T; Reske-Kunz, AB
      Consequences of antigen self-presentation by tumor-specific cytotoxic T cells

      IMMUNOBIOLOGY
    71. Bauer, M; Wagner, H; Lipford, GB
      HPV type 16 protein E7 HLA-A2 binding peptides are immunogenic but not processed and presented

      IMMUNOLOGY LETTERS
    72. Meng, WS; Butterfield, LH; Ribas, A; Heller, JB; Dissette, VB; Glaspy, JA; McBride, WH; Economou, JS
      Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein

      MOLECULAR IMMUNOLOGY
    73. Moalem, S; Percy, ME; Andrews, DF; Kruck, TPA; Wong, S; Dalton, AJ; Mehta, P; Fedor, B; Warren, AC
      Are hereditary hemochromatosis mutations involved in Alzheimer disease?

      AMERICAN JOURNAL OF MEDICAL GENETICS
    74. Murray, JL; Przepiorka, D; Ioannides, CG
      Clinical trials of HER-2/neu-specific vaccines

      SEMINARS IN ONCOLOGY
    75. Eckels, DD
      MHC: Function and implication on vaccine development

      VOX SANGUINIS
    76. Jager, E; Nagata, Y; Gnjatic, S; Wada, H; Stockert, E; Karbach, J; Dunbar, PR; Lee, SY; Jungbluth, A; Jager, D; Arand, M; Ritter, C; Cerundolo, V; Dupont, B; Chen, YT; Old, LJ; Knuth, A
      Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    77. Jager, E; Gnjatic, S; Nagata, Y; Stockert, E; Jager, D; Karbach, J; Neumann, A; Rieckenberg, J; Chen, YT; Ritter, G; Hoffman, E; Arand, M; Old, LJ; Knuth, A
      Induction of primary NY-ESO-1 immunity: CD8+T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+cancers

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    78. Gambotto, A; Cicinnati, V; Robbins, PD
      Genetic approaches for biologic therapy of cancer

      DRUGS OF TODAY
    79. Borenstein, SH; Graham, J; Zhang, XL; Chamberlain, JW
      CD8(+) T cells are necessary for recognition of allelic, but not locus-mismatched or xeno-, HLA class I transplantation antigens

      JOURNAL OF IMMUNOLOGY
    80. Panelli, MC; Bettinotti, MP; Lally, K; Ohnmacht, GA; Li, Y; Robbins, P; Riker, A; Rosenberg, SA; Marincola, FM
      A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12

      JOURNAL OF IMMUNOLOGY
    81. Crotzer, VL; Christian, RE; Brooks, JM; Shabanowitz, J; Settlage, RE; Marto, JA; White, FM; Rickinson, AB; Hunt, DF; Engelhard, VH
      Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines

      JOURNAL OF IMMUNOLOGY
    82. Heidecker, L; Brasseur, F; Probst-Kepper, M; Gueguen, M; Boon, T; Van den Eynde, BJ
      Cytolytic T lymphocytes raised against a human bladder carcinoma recognizean antigen encoded by gene MAGE-A12

      JOURNAL OF IMMUNOLOGY
    83. Scheibenbogen, C; Romero, P; Rivoltini, L; Herr, W; Schmittel, A; Cerottini, JC; Woelfel, T; Eggermont, AMM; Keilholz, U
      Quantitation of antigen-reactive T cells in peripheral blood by IFN gamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial

      JOURNAL OF IMMUNOLOGICAL METHODS
    84. Moreau-Aubry, A; Le Guiner, S; Labarriere, N; Gesnel, MC; Jotereau, F; Breathnach, R
      A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma

      JOURNAL OF EXPERIMENTAL MEDICINE
    85. Colella, TA; Bullock, TNJ; Russell, LB; Mullins, DW; Overwijk, WW; Luckey, CJ; Pierce, RA; Restifo, NP; Engelhard, VH
      Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: Implications for tumor immunotherapy

      JOURNAL OF EXPERIMENTAL MEDICINE
    86. Pique, C; Ureta-Vidal, A; Gessain, A; Chancerel, B; Gout, O; Tamouza, R; Agis, F; Dokhelar, MC
      Evidence for the chronic in vivo production of human T cell leukemia virustype I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides

      JOURNAL OF EXPERIMENTAL MEDICINE
    87. Wolfel, C; Drexler, I; Van Pel, A; Thres, T; Leister, N; Herr, W; Sutter, G; Huber, C; Wolfel, T
      Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope

      INTERNATIONAL JOURNAL OF CANCER
    88. Lewis, JJ; Janetzki, S; Schaed, S; Panageas, KS; Wang, SQ; Williams, L; Meyers, M; Butterworth, L; Livingston, PO; Chapman, PB; Houghton, AN
      Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide

      INTERNATIONAL JOURNAL OF CANCER
    89. Jungbluth, AA; Busam, KJ; Kolb, D; Iversen, K; Coplan, K; Chen, YT; Spagnoli, GC; Old, LJ
      Expression of MAGE-antigens in normal tissues and cancer

      INTERNATIONAL JOURNAL OF CANCER
    90. Carmon, L; El-Shami, KM; Paz, A; Pascolo, S; Tzehoval, E; Tirosh, B; Koren, R; Feldman, M; Fridkin, M; Lemonnier, FA; Eisenbach, L
      Novel breast-tumor-associated MUC1-derived peptides: Characterization in Db-/- x beta 2 microglobulin (beta 2m) null mice transgenic for a chimeric HLA-A2.1/D-b-beta 2 microglobulin single chain

      INTERNATIONAL JOURNAL OF CANCER
    91. Schirle, M; Keilholz, W; Weber, B; Gouttefangeas, C; Dumrese, T; Becker, HD; Stevanovic, S; Rammensee, HG
      Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach

      EUROPEAN JOURNAL OF IMMUNOLOGY
    92. Tourdot, S; Scardino, A; Saloustrou, E; Gross, DA; Pascolo, S; Cordopatis, P; Lemonnier, FA; Kosmatopoulos, K
      A general strategy to enhance immunogenicity of low-affinity HLA-A2.1-associated peptides: implication in the identification of cryptic tumor epitopes

      EUROPEAN JOURNAL OF IMMUNOLOGY
    93. Shaif-Muthana, M; McIntyre, C; Sisley, K; Rennie, I; Murray, A
      Dead or alive: Immunogenicity of human melanoma cells when presented by dendritic cells

      CANCER RESEARCH
    94. Kobayashi, H; Wood, M; Song, YS; Appella, E; Celis, E
      Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen

      CANCER RESEARCH
    95. Nishizaka, S; Gomi, S; Harada, K; Oizumi, K; Itoh, K; Shichijo, S
      A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma

      CANCER RESEARCH
    96. Martelange, V; De Smet, C; De Plaen, E; Lurquin, C; Boon, T
      Identification on a human sarcoma of two new genes with tumor-specific expression

      CANCER RESEARCH
    97. Kawano, K; Gomi, S; Tanaka, K; Tsuda, N; Kamura, T; Itoh, K; Yamada, A
      Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer

      CANCER RESEARCH
    98. Jager, D; Stockert, E; Jager, E; Gure, AO; Scanlan, MJ; Knuth, A; Old, LJ; Chen, YT
      Serological cloning of a melanocyte rab guanosine 5 '-triphosphate-bindingprotein and a chromosome condensation protein from a melanoma complementary DNA library

      CANCER RESEARCH
    99. Daponte, A; Ascierto, PA; Gravina, A; Melucci, MT; Palmieri, G; Comella, P; Cellerino, R; DeLena, M; Marini, G; Comella, G
      Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma - A multicenter Phase II study of the Southern Italy Cooperative Oncology Group

      CANCER
    100. Toh, H; Savoie, CJ; Kamikawaji, N; Muta, S; Sasazuki, T; Kuhara, S
      Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: Molecular dynamics simulations of HLA-A*0217

      BIOPOLYMERS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/08/20 alle ore 17:05:52